Lung cancer trial of RET inhibitor selpercatinib achieves durable responses in majority of patients with RET gene fusions

Aug 28, 2020

Phase I/II trial finds targeted therapy effective in heavily pretreated patients and those with brain metastases HOUSTON ― For patients with non-small cell lung cancers (NSCLC) marked by RET gene fusions, the targeted therapy selpercatinib was well tolerated and achieved durable objective responses, or tumor shrinkage, […]

The Community Hero page celebrates the individuals and organizations making a lasting difference in Katy and the surrounding areas. Each month, we spotlight local heroes whose dedication, compassion, and hard work inspire others—whether they’re first responders, educators, volunteers, business owners, or everyday residents stepping up to help their neighbors.

Through personal stories, interviews, and photos, we honor their contributions and shine a light on the positive impact they have in our community. By sharing their journeys, we hope to encourage others to get involved, foster connections, and remind everyone that small acts of kindness can spark big change.

If you know someone whose efforts deserve recognition, let us know—they could be our next Community Hero.